medigraphic.com
Revista Médica Sinergia

2019, Número 05

Revista Médica Sinergia 2019; 4 (05)


Actualización en patología trofoblástica gestacional: mola hidatiforme y neoplasias

Espinoza AA, Fernández VR, Solar VT

Idioma: Español
Referencias bibliográficas: 25
Paginas: 44-59
Archivo PDF: 357.96 Kb.


RESUMEN

La enfermedad trofoblástica gestacional está compuesta por una gama de patologías poco comunes asociadas al embarazo, que van desde benignas hasta malignas. Es importante realizar un diagnóstico oportuno mediante el uso de ultrasonido; apoyándose con estudios de laboratorio y gabinete, estudios histológicos y moleculares. En términos generales, el tratamiento de la enfermedad molar premaligna va a consistir en la evacuación uterina. El uso de quimioterapeúticos y de intervenciones quirúrgicas, en conjunto con el uso de radioterapia, podría llegar a tener un papel importante en el tratamiento tanto de estas como de las enfermedades trofoblásticas neoplásicas. La hormona gonadotropina coriónica humana es un biomarcador crucial para medir la progresión, respuesta a tratamiento y seguimiento de estas enfermedades. Gracias a la implementación de mejoras en el diagnóstico y tratamiento, la presentación clínica y morbilidad de las enfermedades ha cambiado conforme pasan los años.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Durón R, Bolaños P. Enfermedad Trofoblástica Gestacional. Med Leg Costa Rica [Internet]. 2018 Marzo [citado 2019 Marzo 04]; 35(1):30-43. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152018000100030&lng=en

  2. Tse KY, Chan KK, Tam KF, Ngan HY. Current management of gestational trophoblastic disease. Obstetrics, Gynaecology & Reproductive Medicine. 2015 01;25(1):12-21. https://doi.org/10.1016/j.ogrm.2014.10.007

  3. Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Update on the diagnosis and management of gestational trophoblastic disease. International Journal of Gynecology & Obstetrics. 2018 Oct;143(S2):79-85. https://doi.org/10.1002/ijgo.12615

  4. Barber E, Soper J. Clinical Gynecologic Oncology [Internet]. 9na ed. Philadelphia: Elsevier; c2018. Gestational Trophoblastic Disease; [citado 2019 Marzo 04]. Disponible en: https://www.sciencedirect.com/search?pub=Clinical%20Gynecologic%20Oncology%20%28Ninth%20Editi on%29&cid=316524&show=25&sortBy=relevance

  5. Brown J, Naumann RW, Seckl MJ, Schink J. 15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. Gynecologic Oncology. 2017 01;144(1):200-207. https://doi.org/10.1016/j.ygyno.2016.08.330

  6. Salani R, Copeland L. Obtetrics Normal and Problem Pregnancies. 7th ed. Philadelphia: Elsevier; c2017. Chapter 50, Malignant Diseases and Pregnancy; p.1070-1073.

  7. Parker VL, Tidy JA. Current management of gestational trophoblastic disease. Obstetrics, Gynaecology & Reproductive Medicine. 2017 Nov;27(11):338-345. https://doi.org/10.1016/j.ogrm.2017.08.004

  8. Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, Berkowitz RS, Horowitz NS. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecologic Oncology. 2016 Oct;143(1):73-76. https://doi.org/10.1016/j.ygyno.2016.07.117

  9. Shaaban AM, Rezvani M, Haroun RR, Kennedy AM, Elsayes KM, Olpin JD, Salama ME, Foster BR, Menias CO. Gestational Trophoblastic Disease: Clinical and Imaging Features. RadioGraphics. 2017 03;37(2):681- 700. https://doi.org/10.1148/rg.2017160140

  10. Johns J, Greenwold N, Buckley S, Jauniaux E. A prospective study of ultrasound screening for molar pregnancies in missed miscarriages. Ultrasound in Obstetrics and Gynecology. 2005;25(5):493-497. https://doi.org/10.1002/uog.1888

  11. Mangili G, Lorusso D, Brown J, Pfisterer J, Massuger L, Vaughan M, Ngan HY, Golfier F, Sekharan PK, Charry RC, Poveda A, Kim J, Xiang Y, Berkowtiz R, Seckl MJ. Trophoblastic Disease Review for Diagnosis and Management: A Joint Report From the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup. International Journal of Gynecologic Cancer. 2014 Nov;24(Supp 3):S109-S116. https://doi.org/10.1097/igc.0000000000000294

  12. Khanna P. Enfermedad Trofoblástica Gestacional. Revista Médica De Costa Rica Y Centroamérica [Internet]. 2016 [citado 2019 Marzo 04]; 83(618):173-178. Disponible en: http://revistamedicacr.com/index.php/rmcr/article/view/192/177

  13. Kaur B, Sebire NJ. Gestational trophoblastic tumours and non-neoplastic trophoblastic lesions: morphology and immunocytochemistry to refine the diagnosis. Diagnostic Histopathology. 2019 02;25(2):53-65. https://doi.org/10.1016/j.mpdhp.2018.12.004

  14. Kaur B, Short D, Fisher RA, Savage PM, Seckl MJ, Sebire NJ. Atypical Placental Site Nodule (APSN) and Association With Malignant Gestational Trophoblastic Disease; A Clinicopathologic Study of 21 Cases. International Journal of Gynecological Pathology. 2015 03;34(2):152-158. https://doi.org/10.1097/pgp.0000000000000128

  15. Goldstein D, Berkowitz R, Horowitz N. International Manual of Oncology Practice. 1era ed. Cham: Springer; c2015. Diagnosis and Management of Gestational Trophoblastic Neoplasia; p. 501-513. https://doi.org/10.1007/978-3-319-21683-6_21

  16. Froeling FEM, Seckl MJ. Gestational Trophoblastic Tumours: An Update for 2014. Current Oncology Reports. 2014 Oct 16;16(11): 406. https://doi.org/10.1007/s11912-014-0408-y

  17. Berkowitz RS, Goldstein DP, Horowitz NS. Management Options of Gestational Trophoblastic Disease. Current Obstetrics and Gynecology Reports. 2013 Nov 10;3(1):76-83. https://doi.org/10.1007/s13669-013- 0065-4

  18. Biscaro A, Braga A, Berkowitz RS. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Revista Brasileira de Ginecologia e Obstetrícia. 2015 01;37(1):42-51. https://doi.org/10.1590/so100-720320140005198

  19. Gueye M, Ndiaye-Gueye M, Kane-Gueye S, Gassama O, Diallo M, Moreau J. Diagnosis, Treatment and Outcomes of Gestational Trophoblastic Neoplasia in a Low Resource Income Country. Int J MCH AIDS [Internet]. 2016 [citado 2019 marzo 04]; 5(2):112-118. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187643/

  20. Santaballa A, García Y, Herrero A, Laínez N, Fuentes J, De Juan A, Rodriguez Freixinós V, Aparicio J, Casado A, García-Martinez E. SEOM clinical guidelines in gestational trophoblastic disease (2017). Clinical and Translational Oncology. 2017 Nov 17;20(1):38-46. https://doi.org/10.1007/s12094-017-1793-0

  21. Garcia-Sayre J, Castaneda A, Roman L, Matsuo K. Handbook of Gynecology. 1st ed. Cham: Springer International Publishing; c2017. Diagnosis and Management of Gestational Trophoblastic Disease; p. 1-15.

  22. Lawrie TA, Alazzam M, Tidy J, Hancock BW, Osborne R. First-line chemotherapy in low-risk gestational trophoblastic neoplasia. . Cochrane Database of Systematic Reviews. 2016 06 09; Art. No.: CD007102. https://doi.org/10.1002/14651858.cd007102.pub4

  23. Couder F, Massardier J, You B, Abbas F, Hajri T, Lotz J, Schott A, Golfier F. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone. American Journal of Obstetrics and Gynecology. 2016 07;215(1):80.e1-80.e7. https://doi.org/10.1016/j.ajog.2016.01.183

  24. Patni R. Gestational Trophoblastic Neoplasia: The Role of Surgery Cannot be Undermined!. Indian Journal of Gynecologic Oncology. 2017 Oct 20;15(4): 55. https://doi.org/10.1007/s40944-017-0157-6

  25. Eagles N, Sebire N, Short D, Savage P, Seckl M, Fisher R. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Human Reproduction. 2015 07 22;30(9):2055-2063. https://doi.org/10.1093/humrep/dev169




2020     |     www.medigraphic.com